Anticoagulation shine tsari na rage fibrin thrombus samuwar ta hanyar aikace-aikace na maganin rigakafi don rage tsarin hanyar ciki da kuma hanyar haɗin gwiwa.
Magungunan anti-platelet shine shan magungunan anti-platelet don rage mannewa da aikin tarawa na platelet, don haka rage tsarin samuwar platelet thrombus.A cikin aikin asibiti, magungunan da ake amfani da su na maganin ƙwanƙwasawa sun haɗa da warfarin da heparin, wanda ke rage yiwuwar samuwar fibrinogen thrombus ta hanyoyi daban-daban na anticoagulant.Misali, ana amfani da warfarin sau da yawa wajen maganin ƙwanƙwasawa bayan tiyatar bawul ɗin zuciya, kuma ana yawan amfani da heparin wajen maganin jijiyoyi na ƙananan ƙafafu.
Magungunan antiplatelet na yau da kullun sun haɗa da aspirin, Plavix, da sauransu. Waɗannan magungunan na iya hana haɗuwar platelet ta hanyar haɗin gwiwa daban-daban, ta yadda za su hana samuwar platelet thrombus.A asibiti, ana amfani da shi don rigakafin cututtukan zuciya, thrombosis na cerebral da sauran cututtuka.
SUCCEEDER a matsayin daya daga cikin manyan kamfanoni a cikin China Diagnostic Market of Thrombosis and Hemostasis, SUCCEEDER ya gogaggen ƙungiyoyin R&D, Samfura, Kasuwancin Talla da Sabis ɗin Masu Ba da Sabis da Masu Nazari da Reagents, masu nazarin rheology na jini, masu nazarin ESR da HCT, masu nazarin tattarawar platelet tare da ISO13485 CE Takaddun shaida da FDA da aka jera.